Palliative Radiotherapy for Malignant Neuropathic Pain, Adrenal, Choroidal, and Skin Metastases

Daniel E. Roos, Aaron Wolfson

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

This chapter discusses palliative radiotherapy for malignant neuropathic pain, adrenal, choroidal, and skin metastases. There are very little data in the literature on the use of RT for malignant neuropathic pain. One randomized trial on neuropathic pain due to bone metastases showed similar response rates to those observed for localized bone pain but leaves the question of optimal fractionation open. Both external beam radiation therapy (EBRT) and stereotactic body radiation therapy (SBRT) are effective for palliation of painful adrenal metastases, with response rates of about 85%, although the latter technique is primarily used for local control and disease-free survival benefit. EBRT has been used to treat symptomatic cutaneous metastases from a wide variety of carcinomas and for recurrent/metastatic primary skin malignancies including cutaneous malignant melanoma (CMM), Merkel cell carcinoma (MCC), and primary cutaneous lymphoma (PCL).

Original languageEnglish
Title of host publicationRadiation Oncology in Palliative Cancer Care
PublisherJohn Wiley and Sons
Pages299-316
Number of pages18
ISBN (Print)9781118484159
DOIs
StatePublished - Mar 7 2013

Fingerprint

Neuralgia
Radiotherapy
Neoplasm Metastasis
Skin
Merkel Cell Carcinoma
Bone and Bones
Disease-Free Survival
Lymphoma
Carcinoma
Pain
Neoplasms

Keywords

  • Adrenal metastases
  • Choroidal metastases
  • External beam radiation therapy (EBRT)
  • Malignant neuropathic pain
  • Palliative radiotherapy
  • Skin metastases
  • Stereotactic body radiation therapy (SBRT)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Roos, D. E., & Wolfson, A. (2013). Palliative Radiotherapy for Malignant Neuropathic Pain, Adrenal, Choroidal, and Skin Metastases. In Radiation Oncology in Palliative Cancer Care (pp. 299-316). John Wiley and Sons. https://doi.org/10.1002/9781118607152.ch24

Palliative Radiotherapy for Malignant Neuropathic Pain, Adrenal, Choroidal, and Skin Metastases. / Roos, Daniel E.; Wolfson, Aaron.

Radiation Oncology in Palliative Cancer Care. John Wiley and Sons, 2013. p. 299-316.

Research output: Chapter in Book/Report/Conference proceedingChapter

Roos, DE & Wolfson, A 2013, Palliative Radiotherapy for Malignant Neuropathic Pain, Adrenal, Choroidal, and Skin Metastases. in Radiation Oncology in Palliative Cancer Care. John Wiley and Sons, pp. 299-316. https://doi.org/10.1002/9781118607152.ch24
Roos, Daniel E. ; Wolfson, Aaron. / Palliative Radiotherapy for Malignant Neuropathic Pain, Adrenal, Choroidal, and Skin Metastases. Radiation Oncology in Palliative Cancer Care. John Wiley and Sons, 2013. pp. 299-316
@inbook{a010bc0fc2574c31813b8fa1f7d66d87,
title = "Palliative Radiotherapy for Malignant Neuropathic Pain, Adrenal, Choroidal, and Skin Metastases",
abstract = "This chapter discusses palliative radiotherapy for malignant neuropathic pain, adrenal, choroidal, and skin metastases. There are very little data in the literature on the use of RT for malignant neuropathic pain. One randomized trial on neuropathic pain due to bone metastases showed similar response rates to those observed for localized bone pain but leaves the question of optimal fractionation open. Both external beam radiation therapy (EBRT) and stereotactic body radiation therapy (SBRT) are effective for palliation of painful adrenal metastases, with response rates of about 85{\%}, although the latter technique is primarily used for local control and disease-free survival benefit. EBRT has been used to treat symptomatic cutaneous metastases from a wide variety of carcinomas and for recurrent/metastatic primary skin malignancies including cutaneous malignant melanoma (CMM), Merkel cell carcinoma (MCC), and primary cutaneous lymphoma (PCL).",
keywords = "Adrenal metastases, Choroidal metastases, External beam radiation therapy (EBRT), Malignant neuropathic pain, Palliative radiotherapy, Skin metastases, Stereotactic body radiation therapy (SBRT)",
author = "Roos, {Daniel E.} and Aaron Wolfson",
year = "2013",
month = "3",
day = "7",
doi = "10.1002/9781118607152.ch24",
language = "English",
isbn = "9781118484159",
pages = "299--316",
booktitle = "Radiation Oncology in Palliative Cancer Care",
publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Palliative Radiotherapy for Malignant Neuropathic Pain, Adrenal, Choroidal, and Skin Metastases

AU - Roos, Daniel E.

AU - Wolfson, Aaron

PY - 2013/3/7

Y1 - 2013/3/7

N2 - This chapter discusses palliative radiotherapy for malignant neuropathic pain, adrenal, choroidal, and skin metastases. There are very little data in the literature on the use of RT for malignant neuropathic pain. One randomized trial on neuropathic pain due to bone metastases showed similar response rates to those observed for localized bone pain but leaves the question of optimal fractionation open. Both external beam radiation therapy (EBRT) and stereotactic body radiation therapy (SBRT) are effective for palliation of painful adrenal metastases, with response rates of about 85%, although the latter technique is primarily used for local control and disease-free survival benefit. EBRT has been used to treat symptomatic cutaneous metastases from a wide variety of carcinomas and for recurrent/metastatic primary skin malignancies including cutaneous malignant melanoma (CMM), Merkel cell carcinoma (MCC), and primary cutaneous lymphoma (PCL).

AB - This chapter discusses palliative radiotherapy for malignant neuropathic pain, adrenal, choroidal, and skin metastases. There are very little data in the literature on the use of RT for malignant neuropathic pain. One randomized trial on neuropathic pain due to bone metastases showed similar response rates to those observed for localized bone pain but leaves the question of optimal fractionation open. Both external beam radiation therapy (EBRT) and stereotactic body radiation therapy (SBRT) are effective for palliation of painful adrenal metastases, with response rates of about 85%, although the latter technique is primarily used for local control and disease-free survival benefit. EBRT has been used to treat symptomatic cutaneous metastases from a wide variety of carcinomas and for recurrent/metastatic primary skin malignancies including cutaneous malignant melanoma (CMM), Merkel cell carcinoma (MCC), and primary cutaneous lymphoma (PCL).

KW - Adrenal metastases

KW - Choroidal metastases

KW - External beam radiation therapy (EBRT)

KW - Malignant neuropathic pain

KW - Palliative radiotherapy

KW - Skin metastases

KW - Stereotactic body radiation therapy (SBRT)

UR - http://www.scopus.com/inward/record.url?scp=84886329109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886329109&partnerID=8YFLogxK

U2 - 10.1002/9781118607152.ch24

DO - 10.1002/9781118607152.ch24

M3 - Chapter

AN - SCOPUS:84886329109

SN - 9781118484159

SP - 299

EP - 316

BT - Radiation Oncology in Palliative Cancer Care

PB - John Wiley and Sons

ER -